Delivery Order SPE2DB24D6044-SPE2DB25FLJDS

Award Date 7/2/25
Potential Completion Date 7/3/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes, a medication used to treat various medical conditions. The contract has a firm fixed price, a ceiling value of $2,265.90, and a performance period through May 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) 20 MG/0.2 ML syringes, a prescription medication. The contract is not set aside and has a ceiling value of $4,939.94. The performance period extends through May 29, 2025. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Humira 40 mg/0.8 ml syringes, a specialty medication used for various medical conditions. The contract has a ceiling value of $1,727.32 and a completion date of December 4, 2024. It is a firm fixed-price contract, and no set-aside designation was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA 40 MG/0.8 ML SYRINGES, with a ceiling value of $1,051.10 and a performance period through June 2025. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. The contract has a firm fixed price, does not have a set-aside designation, and has a ceiling value of $7,040.25. The period of performance extends through July 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes, a specialty medication used to treat various medical conditions. The contract has a ceiling value of $8,933.98 and an ultimate completion date of December 26, 2023. The contract is a firm fixed-price delivery order, with no set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of HUMIRA(CF) 20 MG/0.2 ML syringes, a specialty medication. The delivery order is valued at $3,601.25 and has a completion date of November 3, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMIRA 40 MG/0.8 ML SYRINGES, a prescription medication used to treat various medical conditions. The contract has a firm fixed price of $2,085.65 and a period of performance through April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) 40 MG/0.4 ML SYRINGES, a specialty medication, with a ceiling value of $9,732.41 and a completion date of February 13, 2025. The contract is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) 40 MG/0.4 ML SYRINGES, a pharmaceutical product, with a ceiling value of $8,469.10 and a period of performance through May 29, 2025. The contract is not set aside for any socioeconomic program. AmerisourceBergen Drug Corp holds a significant Indefinite...
  • SPE2DB24D6044
    Indefinite Delivery Contract
  • SPE2DB24D6044-SPE2DB25FLJDS
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) 20 MG/0.2 ML syringes, a medication used to treat various medical conditions. The contract has a firm fixed price, with a ceiling value of $1,587.24, and a period of performance ending on July 3, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 10/1/25, 10:06 AM